Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter (15 active)
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (19)
COVID-19 (2)
Type
(
2 selected
)
Type
Guidance (872)
Quality standard (0)
Guidance programme
(
12 selected
)
Guidance programme
Antimicrobial prescribing guidelines (18)
Cancer service guidelines (0)
Clinical guidelines (136)
COVID-19 rapid guidelines (2)
Diagnostics guidance (25)
Health technology evaluations (17)
Highly specialised technologies guidance (23)
Interventional procedures guidance (172)
Medical technologies guidance (55)
Medicines practice guidelines (0)
NICE guidelines (177)
Public health guidelines (14)
Safe staffing guidelines (0)
Social care guidelines (21)
Technology appraisal guidance (422)
Apply filters
Showing 126 to 150 of 872
Sort by
Date
Title
Apply sorting
Last updated date between 1/4/2018 and 28/3/2024
Remove Last updated date between 1/4/2018 and 28/3/2024 filter
Type: Guidance
Remove Type: Guidance filter
Type: Quality standard
Remove Type: Quality standard filter
Guidance programme: Technology appraisal guidance
Remove Guidance programme: Technology appraisal guidance filter
Guidance programme: Interventional procedures guidance
Remove Guidance programme: Interventional procedures guidance filter
Guidance programme: Clinical guidelines
Remove Guidance programme: Clinical guidelines filter
Guidance programme: Medical technologies guidance
Remove Guidance programme: Medical technologies guidance filter
Guidance programme: Diagnostics guidance
Remove Guidance programme: Diagnostics guidance filter
Guidance programme: Highly specialised technologies guidance
Remove Guidance programme: Highly specialised technologies guidance filter
Guidance programme: Social care guidelines
Remove Guidance programme: Social care guidelines filter
Guidance programme: Antimicrobial prescribing guidelines
Remove Guidance programme: Antimicrobial prescribing guidelines filter
Guidance programme: Public health guidelines
Remove Guidance programme: Public health guidelines filter
Guidance programme: Cancer service guidelines
Remove Guidance programme: Cancer service guidelines filter
Guidance programme: Medicines practice guidelines
Remove Guidance programme: Medicines practice guidelines filter
Guidance programme: Safe staffing guidelines
Remove Guidance programme: Safe staffing guidelines filter
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Darolutamide with androgen deprivation therapy and docetaxel for treating hormone-sensitive metastatic prostate cancer
TA903
21 June 2023
21 June 2023
Pembrolizumab with lenvatinib for previously treated advanced or recurrent endometrial cancer
TA904
21 June 2023
21 June 2023
Upadacitinib for previously treated moderately to severely active Crohn's disease
TA905
21 June 2023
21 June 2023
Cemiplimab for treating recurrent or metastatic cervical cancer (terminated appraisal)
TA901
20 June 2023
20 June 2023
Dabrafenib plus trametinib for treating BRAF V600 mutation-positive advanced non-small-cell lung cancer
TA898
14 June 2023
14 June 2023
Tixagevimab plus cilgavimab for preventing COVID-19
TA900
14 June 2023
14 June 2023
Axicabtagene ciloleucel for treating relapsed or refractory follicular lymphoma
TA894
7 June 2023
7 June 2023
Axicabtagene ciloleucel for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy
TA895
7 June 2023
7 June 2023
Bulevirtide for treating chronic hepatitis D
TA896
7 June 2023
7 June 2023
Brexucabtagene autoleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people 26 years and over
TA893
7 June 2023
7 June 2023
FibroScan for assessing liver fibrosis and cirrhosis outside secondary and specialist care
DG48
7 June 2023
7 June 2023
Atopic eczema in under 12s: diagnosis and management
CG57
12 December 2007
7 June 2023
Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma
TA897
6 June 2023
6 June 2023
Esketamine for treating major depressive disorder in adults at imminent risk of suicide (terminated appraisal)
TA899
6 June 2023
6 June 2023
Intraoperative electron beam radiotherapy for locally advanced and locally recurrent colorectal cancer
IPG763
6 June 2023
6 June 2023
Transperineal biopsy for diagnosing prostate cancer
DG54
1 June 2023
1 June 2023
Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia
TA891
31 May 2023
31 May 2023
Mosunetuzumab for treating relapsed or refractory follicular lymphoma
TA892
31 May 2023
31 May 2023
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure from high spinal cord injuries
IPG762
24 May 2023
24 May 2023
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers
DG52
24 May 2023
24 May 2023
MRI fusion biopsy systems for diagnosing prostate cancer
DG53
24 May 2023
24 May 2023
Head injury: assessment and early management
NG232
18 May 2023
18 May 2023
Risankizumab for previously treated moderately to severely active Crohn's disease
TA888
17 May 2023
17 May 2023
Ciltacabtagene autoleucel for treating relapsed or refractory multiple myeloma (terminated appraisal)
TA889
17 May 2023
17 May 2023
Difelikefalin for treating pruritus in people having haemodialysis
TA890
17 May 2023
17 May 2023
Previous page
1
…
4
5
Current page
6
7
8
…
35
Page
6
of
35
Next page
Results per page
10
25
50
All
Back to top